Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 3Terminated 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Plasma cell 1Lymphoid 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 42Lung Neoplasms 32Head and Neck Neoplasms 24Glioblastoma 24Squamous Cell Carcinoma of Head and Neck 22Breast Neoplasms 21Lymphoma 17Brain Neoplasms 17Rectal Neoplasms 16Prostatic Neoplasms 15Lymphoma, Non-Hodgkin 14Leukemia, Lymphocytic, Chronic, B-Cell 13Leukemia 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Follicular 11Gliosarcoma 11Esophageal Neoplasms 11Central Nervous System Neoplasms 11Adenocarcinoma Of Esophagus 11Pancreatic Neoplasms 10Melanoma 10Lymphoma, Large B-Cell, Diffuse 10Hodgkin Disease 10Neoplasm Metastasis 9Multiple Myeloma 9Neoplasms, Plasma Cell 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myeloid, Acute 8Burkitt Lymphoma 8Sarcoma 7

Interventions

fludarabine phosphate 4Cyclosporine 3Cyclophosphamide 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3ruxolitinib 2fludarabine 2Whole-Body Irradiation 2Stem Cell Transplantation 2Radiotherapy 2Methylprednisolone 2Busulfan 2Antilymphocyte Serum 2nelarabine 1arsenous acid 1anagrelide 1Watchful Waiting 1Thiotepa 1Tetradecanoylphorbol Acetate 1Surveys and Questionnaires 1Peripheral Blood Stem Cell Transplantation 1Oxycodone 1Observation 1N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1Mycophenolic Acid 1Moxifloxacin 1Morphine 1Methotrexate 1Methadone 1Liposomes 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Thrombocythemia, Essential × Radiotherapy × Clear all
NCT00066417 2013-05-01

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

National Cancer Institute (NCI)

Phase 2 Terminated
51 enrolled
MyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT00005641 2012-12-11

Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Graft vs Host Disease, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡